Literature DB >> 3680499

Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.

R A Mactier1, R Khanna, Z Twardowski, H Moore, K D Nolph.   

Abstract

The contribution of peritoneal cavity lymphatic absorption to ultrafiltration kinetics and solute clearances in continuous ambulatory peritoneal dialysis was evaluated in patients with normal (group 1) and high (group 2) peritoneal permeability X area during 4-h exchanges using 2 liters 2.5% dextrose dialysis solution with 30 g added albumin. Cumulative lymphatic drainage in all continuous ambulatory peritoneal dialysis (CAPD) patients averaged 358 +/- 47 ml per 4-h exchange and reduced cumulative net transcapillary ultrafiltration at the end of the exchange by 58 +/- 7.2%. The peak ultrafiltration volume was observed before osmotic equilibrium between serum and dialysate was reached and occurred when the net transcapillary ultrafiltration rate had decreased to equal the lymphatic absorption rate. Thereafter the lymphatic absorption rate exceeded the net transcapillary ultrafiltration rate, and intraperitoneal volume decreased. Extrapolated to 4 X 2 liters, 2.5% dextrose, 6-h exchanges per d, lymphatic drainage reduced potential daily net ultrafiltration by 83.2 +/- 10.2%, daily urea clearance by 16.9 +/- 1.9%, and daily creatinine clearance by 16.5 +/- 1.9%. Although lymphatic absorption did not differ between the two groups, lymphatic drainage caused a proportionately greater reduction in net ultrafiltration in group 2 (P less than 0.025), because these patients had more rapid dialysate glucose absorption (P less than 0.05) and less cumulative transcapillary ultrafiltration (P less than 0.01). These findings indicate that cumulative lymphatic drainage significantly reduces net ultrafiltration and solute clearances in CAPD and that ultrafiltration failure in CAPD occurs when daily lymphatic absorption equals or exceeds daily transcapillary ultrafiltration. Reduction of lymphatic absorption may provide a means for future improvement in the efficiency of CAPD.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3680499      PMCID: PMC442385          DOI: 10.1172/JCI113207

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  THE LYMPHATIC PATHWAYS FROM THE PERITONEAL CAVITY: A LYMPHANGIOGRAPHIC STUDY IN THE RAT.

Authors:  T OLIN; T SALDEEN
Journal:  Cancer Res       Date:  1964-11       Impact factor: 12.701

2.  Lecture II: Ascites: the role of the lymphatice in the accumulation of ascitic fluid.

Authors:  F C COURTICE
Journal:  Med J Aust       Date:  1959-12-26       Impact factor: 7.738

3.  Physiological significance of lymph drainage of the serous cavities and lungs.

Authors:  F C COURTICE; W J SIMMONDS
Journal:  Physiol Rev       Date:  1954-07       Impact factor: 37.312

4.  The lymphatic drainage of plasma from the peritoneal cavity of the cat.

Authors:  F C COURTICE; A W STEINBECK
Journal:  Aust J Exp Biol Med Sci       Date:  1950-03

5.  Osmotic agents and ultrafiltration in peritoneal dialysis.

Authors:  Z J Twardowski; R Khanna; K D Nolph
Journal:  Nephron       Date:  1986       Impact factor: 2.847

6.  Structural changes of the diaphragmatic peritoneum in patients with schistosomal hepatic fibrosis: its relation to ascites.

Authors:  A H Ismail; F S Mohamed
Journal:  Lymphology       Date:  1986-06       Impact factor: 1.286

7.  Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study.

Authors:  A Slingeneyer; B Canaud; C Mion
Journal:  Nephron       Date:  1983       Impact factor: 2.847

8.  An hypothesis to explain the ultrafiltration characteristics of peritoneal dialysis.

Authors:  K D Nolph; F N Miller; W K Pyle; R P Popovich; M I Sorkin
Journal:  Kidney Int       Date:  1981-11       Impact factor: 10.612

9.  Three exchanges with a 2.5-liter volume for continuous ambulatory peritoneal dialysis.

Authors:  Z Twardowski; L Janicka
Journal:  Kidney Int       Date:  1981-08       Impact factor: 10.612

10.  Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.

Authors:  T E Wideröe; L C Smeby; S Mjåland; K Dahl; K J Berg; T Wessel Aas
Journal:  Nephron       Date:  1984       Impact factor: 2.847

View more
  8 in total

1.  TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis.

Authors:  Hiroshi Kinashi; Yasuhiko Ito; Masashi Mizuno; Yasuhiro Suzuki; Takeshi Terabayashi; Fumiko Nagura; Ryohei Hattori; Yoshihisa Matsukawa; Tomohiro Mizuno; Yukihiro Noda; Hayato Nishimura; Ryosuke Nishio; Shoichi Maruyama; Enyu Imai; Seiichi Matsuo; Yoshifumi Takei
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

2.  A New Method to Increase Ultrafiltration in Peritoneal Dialysis: Steady Concentration Peritoneal Dialysis.

Authors:  Vicente Pérez-Díaz; Alfonso Pérez-Escudero; Sandra Sanz-Ballesteros; Guadalupe Rodríguez-Portela; Susana Valenciano-Martínez; Sofía Palomo-Aparicio; Esther Hernández-García; Luisa Sánchez-García; Raquel Gordillo-Martín; Hortensia Marcos-Sánchez
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

3.  Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury.

Authors:  Takeshi Terabayashi; Yasuhiko Ito; Masashi Mizuno; Yasuhiro Suzuki; Hiroshi Kinashi; Fumiko Sakata; Takako Tomita; Daiki Iguchi; Mitsuhiro Tawada; Ryosuke Nishio; Shoichi Maruyama; Enyu Imai; Seiichi Matsuo; Yoshifumi Takei
Journal:  Lab Invest       Date:  2015-06-29       Impact factor: 5.662

4.  Risks of peritoneal membrane failure in children undergoing long-term peritoneal dialysis.

Authors:  S P Andreoli; C D Langefeld; S Stadler; P Smith; A Sears; K West
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

5.  Quantitative modeling of the physiology of ascites in portal hypertension.

Authors:  David G Levitt; Michael D Levitt
Journal:  BMC Gastroenterol       Date:  2012-03-27       Impact factor: 3.067

Review 6.  The lymphatics in kidney health and disease.

Authors:  Michael D Donnan; Yael Kenig-Kozlovsky; Susan E Quaggin
Journal:  Nat Rev Nephrol       Date:  2021-06-22       Impact factor: 42.439

Review 7.  Experimental systems to study the origin of the myofibroblast in peritoneal fibrosis.

Authors:  Manreet Padwal; Peter J Margetts
Journal:  Kidney Res Clin Pract       Date:  2016-07-27

Review 8.  Roles of the TGF-β⁻VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis.

Authors:  Hiroshi Kinashi; Yasuhiko Ito; Ting Sun; Takayuki Katsuno; Yoshifumi Takei
Journal:  Int J Mol Sci       Date:  2018-08-23       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.